ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
Micro/Nanorobots for Combating Brain Disorders: Challenges, Advances, and Perspectives.
Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Structural Evolution of Biomedical Microrobots: From Rigid to Soft to Rigid-Soft Integrated Systems.Gels (Basel, Switzerland) · 2026Review
- Hydrogel-Based Micro/Nanorobots for Advanced Biomedical Applications.Gels (Basel, Switzerland) · 2026Review
- The Application of Micro/Nanorobots in Cancer Therapy.Micromachines · 2026Review
- From fragmented neurotechnologies to closed-loop brain health systems: integrating artificial intelligence, digital health, digital twins, and advanced materials for brain disorders.Frontiers in bioengineering and biotechnology · 2026Article
- Magnetic Microrobots for Drug Delivery: A Review of Fabrication Materials, Structure Designs and Drug Delivery Strategies.Molecules (Basel, Switzerland) · 2025Review
- Micro/Nanorobots for Combating Brain Disorders: Challenges, Advances, and Perspectives.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Brain disorders pose a significant global health burden, underscoring the urgent need for innovative therapeutic strategies. Conventional treatments are often hindered by poor drug penetration, systemic side effects, and the complex biological barriers of the central nervous system. In recent years, micro/nanorobots (MNRs) have emerged as promising platforms to overcome these limitations. Operating at the micro- to nanoscale, MNRs can accomplish targeted biomedical tasks through self-propulsion (chemical or biohybrid) or external actuation (acoustic, optical, electric, or magnetic), thus enabling unprecedented precision in therapeutic delivery. This review systematically outlines the challenges in treating brain disorders, including major disease categories and barriers affecting therapeutic efficacy, and highlights emerging strategies addressing these obstacles. The principles of MNR propulsion and spotlight recent advances in applying MNRs is further summarized for brain disorder therapies, with special emphasis on the crucial roles of image guidance and real-time tracking in facilitating clinical translation. Finally, it discusses challenges and provides perspectives on future directions. Overall, the rapid development of MNRs holds transformative potential to reshape therapeutic paradigms and accelerate clinical translation for advanced brain disorder treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.